Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Update (1/12/15): Medtronic Diabetes gave an update on their upcoming diabetes device pipeline at the J.P. Morgan Healthcare Conference. The MiniMed 640G is expected to...
What can obesity learn from seatbelts, airbags, and tobacco? Our interview with Robert Wood Johnson Foundation’s Dr. Marks.
Twitter summary: Apple unveils smart watch with several sleek fitness apps – available early 2015 starting at $349 On September 9, Apple unveiled its first-ever smart...
Kerri Sparling ( Sixuntilme.com ) discusses CGM in the Cloud, explaining what it is and how it works. Sparling writes about its benefits and drawbacks that are leading...
On September 27, Taking Control of Your Diabetes (TCOYD) will host its 6 th annual patient conference in Des Moines, Iowa. Founder Steve Edelman and his team have...
Twitter Summary: @LillyPad receives EU approval for Humalog 200 units/ml Kwikpen – 600 units of insulin in a 3 ml pen, hopeful US resubmission late 2014 Eli Lilly...
Looking forward to this year’s American Diabetes Association in our hometown! Plus, how we can improve health and wellness?
(S)he said what?!?
Twitter summary: FDA grants “tentative approval” to Lilly/BI’s Basaglar – new insulin option will be an alternative to Lantus in future On August 18, Eli Lilly and...
The T1D Exchange: a bold vision to advance the field of type 1 diabetes – part four of our interview with David Panzirer and Dana Ball.
Do people with diabetes feel social stigma? Results from a new survey could change the way we talk about diabetes...
On June 5, Xeris Pharmaceuticals announced that the first patient had been dosed in its phase 2 clinical trial , which is testing “mini-dose” glucagon for the treatment...
The countless things I am thankful for this year…Of course, I am most thankful for the health and happiness of my loving family, who I am lucky to say are my personal...
Twitter summary: Lilly’s new basal #insulin Peglispro superior to Sanofi’s Lantus in A1c reduction, though some potential liver safety and hypo concerns On September 4,...
The curious milestone of a diabetes anniversary.
On July 21, JDRF announced the appointment of Derek Rapp as its interim President and CEO, replacing Jeffrey Brewer, who has held the position for the past four years...
twitter summary: what's impt. for #diabetes, tell the @US_FDA your thoughts at https://collaboration.fda.gov/diabetestownhall2014 On November 3, the FDA will host an...
(S)he said what!?
On April 29, the California State Assembly is set to consider bill AB-1893, which, if approved, would require all sharps to be sold with a waste container. This would...
Twitter summary: New Sanofi & MannKind partnership to bring inhaled insulin Afrezza to US in early 2015, presumably primarily to type 2 patients to start On August...

Pages